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UNC-51 like kinase (ULK1) translocates to dysfunctional mitochondria and is involved in mitophagy,
but the mechanisms responsible for ULK1 activation and translocation remain unclear.
Here, we found that hypoxia induces phosphorylation of ULK1 at Serine-555 by Adenosine
50-monophosphate (AMP)-activated protein kinase (AMPK). Unlike wild-type ULK1, an ULK1
(S555A) mutant cannot translocate to mitochondria in response to hypoxia. Inhibition or knock-
down of AMPK prevents ULK1 translocation and inhibits mitophagy. Finally, the phospho-mimic
ULK1 (S555D) mutant, but not ULK1 (S555A), rescues mitophagy in AMPK-knockdown cells. Thus,
we conclude that AMPK-dependent phosphorylation of ULK1 is critical for translocation of ULK1
to mitochondria and for mitophagy in response to hypoxic stress.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction survival [1–5]. At present, mitochondrial autophagy mediated byMitophagy is a process in which autolysosomes eliminate dam-
aged mitochondria to sustain the energy balance or maintain cellPARKIN/PINK1 is a relatively clear signal transduction pathway:
In healthy mitochondria, PINK1 is constitutively expressed and
imported, probably via the TIM/TOM complex, to the inner mem-
brane where it is cleaved by presenilin-associated rhomboid-like
protein (PARL) and ultimately proteolytically degraded. When the
mitochondrial membrane potential is lost, PINK1 is stabilized on
the outer mitochondrial membrane to recruit Parkin to depolarize
the mitochondria, where Parkin ubiquitinates a subset of protein
substrates to trigger mitophagy [1,4]. The autophagy initiating fac-
tor, ULK1, belonging to the Serine/Threonine kinase family, is
required for autophagy induction [6–9]. ULK1 forms a complex
with Atg13 and FIP200 to regulate the initial step of autophagy
induction in mammalian cells. Formation of the ULK1–Atg13–
FIP200 protein complex is not altered by nutrient conditions unlike
its yeast counterpart, the Atg1–Atg13–Atg17 complex [10–12].
However, deletion of any of these factors does not lead to severe
impairment of autophagy under starvation conditions [13]. In
1848 W. Tian et al. / FEBS Letters 589 (2015) 1847–1854addition, even in ULK1/ULK2/ MEFs, long-term glucose with-
drawal is able to induce autophagy [14,15], suggesting that in dif-
ferent cell types, the autophagy pathway responds in different
ways to nutrient depletion [16].
Despite the confusion surrounding its function in
starvation-induced autophagy, ULK1 plays a signiﬁcant role during
terminal erythroid maturation, because ULK1 null reticulocytes
display delayed mitochondrial clearance during red blood cell
development [17,18], indicating that ULK1 has a more speciﬁc role
in mitophagy. Several proteins are involved in hypoxia-induced
mitophagy in mammalian cells, including the mitophagy receptors
NIX and FUNDC1 [19], or the regulatory kinases ULK1 and SRC [20–
24]. In hypoxic conditions, mitochondrial outer membrane pro-
teins like NIX and FUNDC1 are required for mitophagy by interact-
ing with LC3 to recruit autophagic membranes. ULK1 or SRC
regulates the phosphorylation status of FUNDC1 by enhancing or
reducing FUNDC1-LC3 binding [17,21,22].
AMPK positively regulates autophagy under starvation condi-
tions, while mTOR plays a negative role in this process [25–28].
However, both AMPK and mTORC1 are able to phosphorylate
ULK1 and directly regulate its kinase activity. The interaction of
ULK1 with AMPK is inﬂuenced by phosphorylation of ULK1 by
mTORC1, and the interaction between ULK1 and mTORC1 is inﬂu-
enced by phosphorylation of ULK1 by AMPK [25,26,29].
Additionally, the phosphorylation of ULK1 in turn acts in a feed-
back loop to phosphorylate and thereby regulate AMPK or
mTORC1 [30–32]. Therefore, the phosphorylation of ULK1 determi-
nes its function in autophagy. Loss of AMPK a1 or ULK1 results in
aberrant accumulation of autophagy-related proteins and defective
mitophagy. AMPK-phosphorylated ULK1 is required for mitochon-
drial homeostasis and cell survival, and connects cellular energy
sensing to mitophagy [25].
We recently identiﬁed FUNDC1 as a new substrate of ULK1. It
recruits ULK1 to damaged mitochondria, regulating autophagic
clearance of damaged mitochondria in hypoxic conditions [21].
Nevertheless, the phosphorylation status of ULK1 during hypoxia
and the mechanism that triggers mitochondrial translocation of
ULK1 have yet to be revealed. Here, we found that phosphorylation
of ULK1 at Serine-555 by AMPK is involved in translocation of
ULK1 to mitochondria and in mitophagy.2. Materials and methods
2.1. Antibodies and reagents
The following primary antibodies were used in this study:
anti-AMPKa1 antibody (Cell Signaling Technology, #2532),
anti-PRKAA1 (AMPKa) antibody (Thermo, MA5-15815),
anti-phospho-AMPK a1 antibody (Cell Signaling Technology,
#2535), anti-ULK1 antibody (H-240) (Santa Cruz, sc-33182),
anti-Atg1/ULK1 antibody (Sigma, A7481), anti-ULK1 (D8H5) rabbit
mAb (Cell Signaling Technology, #8054), anti-phospho-ULK1
(Ser757) rabbit mAb (Cell Signaling Technology, #6888),
anti-phospho-ULK1 (Ser555) rabbit mAb (Cell Signaling
Technology, #5869), anti-phospho-ULK1 (Ser317) rabbit mAb (Cell
Signaling Technology, #12753), anti-p62/SQSTM1 antibody (MBL,
PM045), anti-beta-Actin antibody (Santa Cruz, sc-47778),
anti-LC3B polyclonal antibody (Sigma, L7543), anti-LC3 polyclonal
antibody (MBL, PM036), anti-TIM23 (BD Biosciences, 611222),
anti-TOM20 (FL-145) (Santa Cruz, sc-11415), anti-VDAC1 mono-
clonal antibody (Abcam, ab14734), anti-FUNDC1 polyclonal anti-
body (Aviva, ARP53280_P050), anti-HA Clone 16B12 monoclonal
antibody (Covance, MMS-101R). Secondary antibodies used for
western blotting were: HRP afﬁnipure goat anti-mouse IgG
(Earthox, E030110), HRP afﬁnipure goat anti-rabbit IgG (Earthox,E030120) and HRP-conjugated goat anti-rabbit IgG Fc
(SouthernBiotech, 4041-05). The following ﬂuorescent secondary anti-
bodies were obtained from Life Technologies: Alexa Fluor 488-labeled
donkey anti-mouse IgG (A21202), Alexa Fluor 488-labeled donkey
anti-rabbit IgG (A21206), Alexa Fluor 555-labeled donkey anti-mouse
IgG (A31570), Alexa Fluor 555-labeled donkey anti-rabbit IgG
(A31572).BaﬁlomycinA1(50 nM,B1793)andMetforminhydrochloride
(2mM, PHR1084-500MG) were purchased from Sigma. Dorsomorphin
2HCl (1 lM, S7306) was purchased from Selleck. Protein A/G
plus-agarose immunoprecipitation reagent (Santa Cruz, sc-2003), and
Lipofectamine 2000 (Invitrogen, 11668027) were used according to
the manufacturer’s protocol.
2.2. Plasmids and siRNA
HA-AMPK and HA-ULK1 S317A were given as gifts by Prof.
Kun-Liang Guan. HA-ULK1 (S555A) was gifted by Dr. Georg
Ramm. HA-hULK1 (deposited by Do-Hyung Kim) was obtained
from Addgene. HA-AMPK KD (kinase dead), HA-ULK1 (S555D)
and HA-ULK1 (S757A) were created by site-directed mutagenesis
using HA-AMPK and HA-ULK1 as the templates. Mutations were
conﬁrmed by sequencing. SiRNA sequences for AMPK a1 subunit,
oligo1: 50-CCCAUAUUAUUUGCGUGUAdTdT-30; oligo2: 50-GAATC
CTGTGACAAGCACAdTdT-30.
2.3. Cell culture and transfection
HeLa, ULK1 (+/+) MEFs and ULK1 (/) MEFs (deposited by Dr.
Sharon Tooze) were cultured in DMEM (Gibco) supplemented with
10% fetal bovine serum (Hyclone) and 1% penicillin/streptomycin
at 37 C under 5% CO2. Hypoxic conditions were achieved with a
hypoxic chamber (Billups–Rothenberg) ﬂushed with a
pre-analyzed gas mixture of 1% O2, 5% CO2, and 94% N2.
Transfection with siRNA was performed according to the manufac-
turer’s protocol. Plasmids were transfected into cells using
Lipofectamine 2000 (Invitrogen).
2.4. Subcellular fractionation
Cells were collected and resuspended in hypotonic buffer
(10 mM KCl, 210 mM sucrose, 70 mM mannitol, 1 mM EDTA,
1 mM EGTA, 1.5 mMMgCl2, 10 mM HEPES; pH adjusted to 7.4 with
KOH). After gentle homogenization with a Dounce homogenizer
(about 50 times), cell extracts were centrifuged at 3000g for
10 min at 4 C. The supernatant was removed to an eppendorf tube
and 100 ll was set aside in another eppendorf as the post-nuclear
supernatant (PNS). The remaining supernatant was centrifuged at
10000g for 10 min and the new supernatant was removed and
set aside as the cytoplasmic fraction (Cyto). The pellet was washed
twice with hypotonic buffer, resuspended in 0.5 ml hypotonic buf-
fer, then layered on top of a step Percoll (GE Healthcare Life
Science) gradient (2 ml 80%, 4.5 ml 52%, 4.5 ml 26% in a SW40
tube) which was centrifuged at 20000g for 2 h. A 0.4 ml fraction
(the mitochondrial fraction, Mito) was collected from the interface
between the 26% and 52% layers and diluted with 0.8 ml hypotonic
buffer. The Mito fraction was centrifuged in an eppendorf tube at
20000g for 10 min and washed 3 times with hypotonic buffer.
Samples were mixed with 100 ll 1 loading buffer and heated
for 10 min at 100 C before analyzing by western blotting.
2.5. SDS–PAGE and western blotting
Cells were lysed in lysis buffer (20 mM Tris–Cl, pH 7.5, 150 mM
NaCl, 2 mM EDTA, 1.5 mM Na3VO4, 50 mM NaF, 10 mM
b-glycerophosphate, 1% triton, phosphatase inhibitor) with 1 mM
PMSF and protease inhibitor cocktail (Roche Applied Science).
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and transferred to PVDF membranes (Millipore). Membranes were
probed with the indicated primary antibodies, followed by the appro-
priate HRP-conjugated secondary antibodies. Immunoreactive bands
were visualized with Pro-light HRP (Tiangen) or Immobilon
Western Chemiluminescent HRP Substrate (Millipore). For quanti-
tation of the bands on the immunoblot, we scanned the ﬁlms and
analyzed the scans using ImageJ software (NIH). Beta-actin levels
were used to correct for gel loading differences.
2.6. Immunoﬂuorescence microscopy
When the treated cells had grown to 70% conﬂuence on a cov-
erslip, they were washed twice with PBS (pre-warmed), and ﬁxed
with freshly prepared 4% paraformaldehyde (pre-warmed) at
37 C for 20 min. Antigen accessibility was increased by treatment
with 0.1% Triton X-100 on ice. After blocking with 2% BSA (bovine
serum albumin), ﬁxed cells were incubated with primary antibod-
ies for 1 h at room temperature, washed with PBS, then stained
with a secondary antibody for a further 1 h at room temperature.
Cell images were captured with a TCS SPF5 II Leica confocal micro-
scope. Colocalization analysis was done by ImageJ software using
the ‘‘RG2B colocalization’’ ImageJ plugin (using default parame-
ters). LC3 puncta were counted automatically by ImageJ.
2.7. Immunoprecipitation
After culturing under hypoxic condition for 12 h, cells were
lysed in 1 ml of lysis buffer (50 mM Tris–Cl pH 7.5, 150 mM
NaCl, 1 mM EDTA, 1% NP-40, 30% glycerin) containing 1 mM
PMSF and protease inhibitor cocktail (Roche Applied Science) for
30 min on ice. Followed by 10000g centrifugation for 10 min,
the lysates were immunoprecipitated with speciﬁc antibody and
protein A/G plus-agarose immunoprecipitation reagent (Santa
Cruz) overnight at 4 C. The precipitants were then washed 5 times
with lysis buffer, and the immune complexes were eluted with
sample buffer containing 1% SDS for 10 min at 100 C and analyzed
by 12% SDS–PAGE.
2.8. Electron microscopy
Electron microscopy was performed as described previously
[33]. Brieﬂy, cells were ﬁxed in 2.5% glutaraldehyde in 0.1 M
sodium phosphate buffer, pH 7.4, at 37 C for 2 h, and then dehy-
drated in a graded ethanol series and embedded. Approximately
70 nm ultrathin sections were mounted on copper grids. The sam-
ples were then stained and visualized using a 120 kV Jeol electron
microscope (JEM-1400) at 80 kV. Images were captured using a
Gatan-832 digital camera.
2.9. Statistical analysis
Assays for characterizing cell phenotypes were analyzed by
Student’s t-test, and correlations between groups were calculated
using Pearson’s test. P values <0.01 were deemed statistically
signiﬁcant.
3. Results
3.1. Hypoxia induces changes in ULK1 phosphorylation and promotes
translocation of ULK1 to mitochondria
How is ULK1 phosphorylated in response to hypoxic
conditions? We ﬁrst examined the expression of ULK1 and its
phosphorylation at three candidate phosphorylation sites
(Ser-317, Ser-555, or Ser-757) [34]. The protein level of ULK1 ismarkedly elevated in response to hypoxia; however, the three
phosphorylation sites are modiﬁed differently (Fig. 1A). The phos-
phorylation of Serine-317 and Serine-555 increases, although the
latter site shows much stronger phosphorylation than the former.
In contrast, phosphorylation of Serine-757 decreases sharply
(Fig. 1A). In the meantime, the phosphorylation of threonine-172
in AMPK a1 also increases in responses to hypoxia, but the protein
level of AMPK a1 is not signiﬁcantly changed (Fig. 1A). Subcellular
fractionation assays demonstrate that in hypoxic cells, a propor-
tion of ULK1 and phosphorylated ULK1 (Ser-555) can be detected
in the fraction that is enriched in mitochondrial components
(Fig. 1B). Further, immunoprecipitation experiments reveal that
the binding of ULK1 with AMPK a1 is much stronger in
hypoxic than in normoxic conditions, while the interaction of
ULK1 and mTOR is stronger in normoxic conditions (Fig. 1C).
Immunoﬂuorescence results show that mutating Ser-555 to ala-
nine (S555A) abolishes the translocation of ULK1 to mitochondria
under hypoxia. As a control, mutating Ser-757 to alanine
(S757A), which removes the site phosphorylated by mTORC1,
markedly affects the translocation of ULK1 (Fig. 1D and E). To be
noted, the total number of ULK1 punctate has not signiﬁcantly
changed in cells transfected ULK1 (WT), ULK1 (S555A), or ULK1
(S757A) (Fig. 1F).
3.2. AMPK a1-dependent phosphorylation of ULK1 is critical for
translocation of ULK1 to mitochondria in response to hypoxia
In order to investigate whether AMPK a1 is the critical factor
for ULK1 phosphorylation and mitochondrial translocation
under hypoxia, we determined the phosphorylation status of
ULK1 following different treatments, including inhibition of
AMPK a1 activity by the agonist Dorsomorphin 2HCl or siRNA
knock-down of AMPK a1. As shown in Fig. 2A, Dorsomorphin
2HCl effectively blocks the phosphorylation of AMPK a1 at
Thr-172 under hypoxic conditions. Meanwhile, the
hypoxia-induced phosphorylation of ULK1 at Ser-555 and
Ser-317 also vanishes completely, whereas phosphorylation of
Ser-757 is not obviously changed. Similar changes in phosphory-
lation status are observed when the endogenous AMPK a1 is
knocked down in MEF cells by siRNA. Phosphorylation of AMPK
a1 at Thr-172 and ULK1 at Ser-555 and Ser-317 are abolished
under hypoxia, whereas phosphorylation of ULK1 at Ser-757
decreases slightly (Fig. 2B). The protein level of ULK1 does not
change after blocking AMPK a1 activity or knocking down
endogenous AMPK a1 (Fig. 2B).
Immunoﬂuorescence shows that ULK1 translocates to the mito-
chondria in hypoxic cells. However, after blocking the activity of
AMPK a1 or knocking down the endogenous AMPK a1, ULK1 no
longer translocates to the mitochondria when cells are exposed
to hypoxia (Fig. 2C and D).
3.3. Ser-555 of ULK1 plays an important role in hypoxia-induced
mitophagy
Next, we examined the role of ULK1 Ser-555 phosphorylation in
hypoxia-induced mitophagy. Under hypoxic conditions, depletion
of endogenous ULK1 inhibits degradation of mitochondrial
proteins including VDAC, TOM20 and TIM23, as well as the
autophagy substrate p62. Similar results were observed in ULK1
(WT) MEFs treated with Baﬁlomycin A1 (Baf1) under hypoxia
(Fig. 3A and B). Reconstitution of exogenous ULK1 in ULK1 KO cells
restores mitophagy under hypoxic conditions. Adding the ULK1
(S555A) mutant cannot restore mitophagy in hypoxic ULK1 KO
cells. However, introducing the phospho-mimic mutant ULK1
(S555D) into ULK1 KO cells markedly stimulates mitophagy
(Fig. 3A and B). Ultrastructure analysis by electron microscopy
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Fig. 1. Hypoxia induces changes in ULK1 phosphorylation and promotes translocation of ULK1 to mitochondria. (A) Western blot analysis of MEFs exposed to hypoxia (1% O2)
for the indicated times. Levels of indicated proteins were detected by the corresponding antibodies. (B) Immunoblots of subcellular fractions from control MEFs or MEFs that
were exposed to hypoxia (1% O2) for 12 h. PNS, post-nuclear supernatant; Cyto, cytosol; Mito, mitochondria. (C) MEFs were cultured under hypoxia for 12 h, and then cell
lysates were immunoprecipitated with anti-ULK1 antibody. (D) HeLa cells were exposed to hypoxia (1% O2) for 12 h after transfection with HA-ULK1-WT, HA-ULK1 (S555A)
or HA-ULK1 (S757A), and then ﬁxed in 4% paraformaldehyde. Cells were stained with anti-HA (mouse) and anti-TOM20 (rabbit) primary antibodies then Alexa Fluor 488-
labeled donkey anti-mouse IgG and Alexa Fluor 555-labeled donkey anti-rabbit IgG secondary antibodies before analysis by immunoﬂuorescence microscopy. Arrows
indicate ULK1 puncta that colocalize with mitochondria. Bar, 10 lm. (E) Quantiﬁcation of the ULK1 puncta that colocalize with mitochondria (mean = S.D.; n = 20 cells from
three independent experiments; ***P < 0.001). (F) Quantiﬁcation of the total ULK1 puncta in cells transfected with ULK1 (WT), ULK1 (S555A) or ULK1 (S757A) (Data were from
three independent experiments; N.S. = Not Signiﬁcant).
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ULK1 (S555A) to mediate mitophagy in ULK1 null cells. ULK1
(S555D) restores the formation of mitochondrion-containing
autophagosomes (mitophagosomes) while ULK1 (S555A) does
not (Fig. 3C).
It was reported previously that during hypoxia-induced mito-
phagy, ULK1 phosphorylates FUNDC1 and thereby enhances the
binding of FUNDC1 to LC3. Here, we found that when ULK1 wasimmunoprecipitated with an anti-FUNDC1 antibody, a consider-
able proportion was phosphorylated at Serine-555 (Fig. 3D).
3.4. AMPK a1 is required for ULK1-dependent mitophagy induced by
hypoxia
To further elucidate the function of AMPK a1 and its substrate
ULK1 in hypoxia-induced mitophagy, we examined normal or
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induction of mitophagy under hypoxia in AMPK a1-knockdown
cells. In wild-type (WT) cells, AMPK is activated by hypoxia, as
indicated by phosphorylation of Thr-172. The phosphorylation of
ULK1 Ser-555 is signiﬁcantly enhanced, while ULK1 Ser-757 is
dephosphorylated compared to normoxia (Fig. 4A and B). In
AMPK a1-knockdown cells, which do not undergo mitophagy
under normoxia, phosphorylation of ULK1 Ser-757 is slightly
elevated. When exogenous AMPK a1 or its constitutively phospho-
rylated substrate ULK1 (S555D) was reconstituted in AMPK
a1-knockdown cells, the hypoxia-induced autophagic degradation
of mitochondrial proteins TIM23, TOM20 and VDAC and the autop-
hagy substrate p62 were restored. Both LC3-I and LC3-II alsodecreased under these conditions (Fig. 4A and B). Meanwhile,
AMPK a1 kinase dead (AMPK a1 KD), wild-type ULK1 and ULK1
(S555A) all failed to rescue the mitophagy process in AMPK
a1-knockdown cells exposed to hypoxia (Fig. 4A and B).
Next, we used immunoﬂuorescence and EM to monitor the
colocalization of LC3 and mitochondria and the formation of
mitophagosomes. In hypoxic cells, extensive colocalization of LC3
and mitochondria was observed (Fig. 4C and D) and mitophago-
somes were detected by EM (Fig. 4E). Metformin, an AMPK a1
kinase activator, is able to promote the colocalization of LC3 and
mitochondria and induce mitophagosome formation even without
hypoxic treatment (Fig. 4E). However, knocking down endogenous
AMPK a1 or adding the AMPK inhibitor Dorsomorphin 2HCl
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Fig. 3. Ser-555 of ULK1 plays an important role in hypoxia-induced mitophagy. (A) ULK1 (+/+) and ULK1 (/) cells, and ULK1 (/) cells transfected with HA-ULK1WT, HA-
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immunoblotted to detect the indicated proteins. (B) Quantiﬁcation of the ratio of p62, VDAC1, TIM23 and TOM20 to Actin in (A). Data were from three independent
experiments. (C) ULK1 (/) MEFs were transfected with HA-ULK1 (S555A) or HA-ULK1 (S555D), cultured under hypoxic (1% O2) conditions for 6 h, then analyzed by electron
microscopy. Red asterisks mark mitophagosomes. Yellow arrows indicate double-membraned autophagosomes. (D) MEFs were cultured under hypoxia for 12 h, and then cell
lysates were immunoprecipitated with anti-FUNDC1 antibody.
1852 W. Tian et al. / FEBS Letters 589 (2015) 1847–1854inhibits the appearance of mitophagic puncta in hypoxic cells
without obviously affecting the formation of single-membraned
autolysosomes (Fig. 4E).
4. Discussion
AMPKis regardedasapotential candidate inmitophagyregulation
because it maintains cellular energy homeostasis by sensing and
manipulating energy status. It inﬂuences the erythrocyte life span
byaccumulatingdysfunctionalmitochondria and responding to reac-
tive oxygen species (ROS) [35,36]. Defective autophagy-dependent
mitochondrial clearance andaccumulationof damagedmitochondria
have been observed in the blood cells of AMPK a1 (/) mice; these
abnormalitieswere corrected by transplantation ofWTbonemarrow
[25]. Hypoxia can trigger AMPK a1 activation through
ROS-dependent CRAC (calcium release-activated calcium) channel
activation, leading to an increase in cytosolic calcium that activates
the AMPK a1 upstream kinase CaMKKb [35]. Regulation of ULK1, an
autophagy initiating kinase, plays a central role in general autophagy,
in particular in autophagosome formation [11]. However, recent
studies indicate that it has a selective function in mitophagy uponstimulation by different environmental cues. ULK1 has been identi-
ﬁedas the substrate of AMPKa1which connects cellular energy sens-
ing to mitophagy in glucose or nutrient starvation-induced
autophagy [16,17,22]. Several potential ULK1 phosphorylation sites
have been identiﬁed in these studies, but the dynamic changes in
the phosphorylation status of ULK1 during hypoxia are not clear. In
our study, hypoxia signiﬁcantly induced AMPK a1 activation as indi-
cated by phosphorylation at Thr-172 (Fig. 1A), which is consistent
with AMPK activation in response to other stimuli including glucose
withdrawal or energy depletion [25,26,32,35]. Phosphorylation of
ULK1 at Ser-555 and Ser-317 also increased dramatically under
hypoxia, while phosphorylation at Ser-757 decreased (Fig. 1A).
Interestingly, the phosphorylation pattern of ULK1 under
hypoxic conditions is similar to that in glucose or nutrient
starvation-induced autophagy, suggesting that a common mecha-
nism of ULK1 activation is shared between general autophagy and
mitophagy [25,26,30,32,35].
The changes in phosphorylation status are possibly due to the
actions of the different binding partners of ULK1 during hypoxia,
since the ULK1/AMPK a1 interaction is increased in hypoxic cells
while the ULK1/mTOR interaction is decreased (Fig. 1C). In
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Fig. 4. AMPK a1 is required for ULK1-dependent mitophagy induced by hypoxia. (A) MEF cells were exposed to hypoxic conditions for 24 h, and the rescuing effect of HA-
AMPK, HA-AMPK KD, HA-ULK1 WT, HA-ULK1 (S555A) or HA-ULK1 (S555D) was examined after endogenous AMPK was knocked down with si-AMPK. Cell lysates were
immunoblotted for the indicated proteins. (B) Quantiﬁcation of the ratio of p62, VDAC1, TIM23 and TOM20 to Actin in (A). Data were from three independent experiments. (C)
MEFs were cultured under hypoxia for 6 h and treated with Dorsomorphin 2HCl (1 lM) to inhibit AMPK, si-AMPK to knock down endogenous AMPK, or Metformin (2 mM) to
activate AMPK. The cells were ﬁxed in 4% paraformaldehyde and stained with anti-TIM23 (mouse) and anti-LC3 (rabbit) primary antibodies then Alexa Fluor 488-labeled
donkey anti-mouse IgG and Alexa Fluor 555-labeled donkey anti-rabbit IgG secondary antibodies before analysis by immunoﬂuorescence microscopy. Bar, 10 lm. (D)
Quantiﬁcation of the translocated ULK1 puncta (mean = S.D.; n = 20 cells from three independent experiments; **P < 0.01; ***P < 0.001). (E) Cells were treated as in (C), and
then analyzed by electron microscopy. Red asterisks mark mitochondrion-containing mitophagosomes. Red arrows indicate autolysosomes.
W. Tian et al. / FEBS Letters 589 (2015) 1847–1854 1853mitophagy, the phosphorylation of ULK1 at Ser-555 and Ser-317 is
increased, which may be due to the strengthened binding of AMPK
a1 with ULK1 (Fig. 1C). In contrast, under normoxic conditions, the
activity of AMPK is inhibited by mTORC1 binding, as shown by the
absence of phosphorylation at Ser-757 of ULK1 (Fig. 1A and C).ULK1 translocates to dysfunctional mitochondria during mito-
phagy initiation, yet the upstream ULK1 activator has not been
reported. In our study, inhibition of AMPK a1 activation or silenc-
ing of AMPK a1 results in loss of ULK1 phosphorylation at Ser-555
and disturbs the translocation of ULK1 to mitochondria, suggesting
1854 W. Tian et al. / FEBS Letters 589 (2015) 1847–1854that AMPK a1 may be an ULK1 activator during hypoxia-induced
mitophagy (Fig. 2A and B). Deletion of ULK1 retards mitophagy
induction upon hypoxia treatment, while ULK1 (S555D), which
mimics constitutively phosphorylated ULK1, rescues mitophagy
induction in ULK1/ MEFs (Fig. 3A–C). These results indicate that
phosphorylation of ULK1 at Ser-555 is essential for mitophagy to
proceed normally (Fig. 3A–C). We monitored the induction of mito-
phagy by labeling LC3 and mitochondria. Hypoxia and the AMPK
a1 activator Metformin were able to induce mitophagy, while
silencing or inhibition of AMPK a1 impaired normal mitophagy
induction under hypoxia (Fig. 4). We silenced the expression of
AMPK a1 in MEFs and found that ULK1 (S555D), which mimics
constitutively phosphorylated ULK1, rescues the impaired
mitophagy resulting from AMPK a1 knockdown (Fig. 4).
In conclusion, we found that AMPK a1 phosphorylates and acti-
vates ULK1, and the activated form of ULK1 translocates to the
mitochondria in hypoxia-induced mitophagy. Moreover, the
ULK1 (S555D) mutant, which mimics constitutive phosphorylation
of ULK1 at Ser-555 by AMPK a1, is able to restore the impaired
mitophagy resulting from AMPK a1 silencing or inhibition. Thus,
our results revealed that AMPK and ULK1 work co-operatively in
mitophagy induced by hypoxia.
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